POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening
SLAS Discovery · 2024
DOI: 10.1016/j.slasd.2024.100156 ↗Kurz gefasst
Fachartikel in der Zeitschrift SLAS Discovery, 2024. Verfasst von Alice Lanne und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK. Hauptthemen laut MEDLINE: High-Throughput Screening Assays, Fluorescent Dyes. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Fluorescent probe modulation assays are a widely used approach to monitor displacement or stabilisation of fluorescently labelled tool ligands by test compounds. These assays allow an optical read-out of probe-receptor binding and can be used to detect compounds that compete with the labelled ligand, either directly or indirectly. Probes for both orthosteric and allosteric sites are often employed. The method can also be used to identify test compounds that may stabilise the ternary complex, offering an opportunity to discover novel molecular glues. The utility of these fluorescence-based assays within high-throughput screening has been facilitated by the use of streptavidin labelled terbium as a donor and access to a range of different acceptor fluorophores. During 2023, the High-throughput Screening group at AstraZeneca carried out 8 high-throughput screens using these approaches. In this manuscript we will present the types of assays used, an overview of the timelines for assay development and screening, the application of orthogonal artefact methods to aid hit finding and the results of the screens in terms of hit rate and the number of compounds identified with IC50 values of better than 30 µM. Learning across the development, execution and analysis of these screens will be presented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
- Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Alderley Park, Macclesfield, UK.
- Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK. Electronic address: geoff.holdgate@astrazeneca.com.
Zitieren
APA
Lanne, A., Bardelle, C., Davies, G., Turberville, A., Semple, H., Moore, R., & Holdgate, G. A. (2024). POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening. SLAS Discovery. https://doi.org/10.1016/j.slasd.2024.100156
Vancouver
Lanne A, Bardelle C, Davies G, Turberville A, Semple H, Moore R, et al. POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening. SLAS Discovery. 2024. doi:10.1016/j.slasd.2024.100156
BibTeX
@article{Lanne2024,
author = {Lanne, Alice and Bardelle, Catherine and Davies, Gareth and Turberville, Antonia and Semple, Hannah and Moore, Rachel and Holdgate, Geoffrey A},
title = {POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening},
journal = {SLAS Discovery},
year = {2024},
doi = {10.1016/j.slasd.2024.100156}
}
EUVIMED